ENCOMPASS HEALTH DEACONESS REHABILIT
1. Target Overview & Investment Thesis
ENCOMPASS HEALTH DEACONESS REHABILIT is a 98-bed suburban community hospital in VANDERBURGH, IN with $50.2M in net patient revenue and a 29.7% operating margin. The hospital serves a payer mix of 55.7% Medicare, 0.8% Medicaid, and 43.6% commercial.
Thesis: Turnaround. Our ML models identify $3.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 29.7% to 37.1% (+736bps).
| Net Revenue HCRIS | $50.2M |
| Current EBITDA COMPUTED | $14.9M |
| Operating Margin COMPUTED | 29.7% |
| Occupancy HCRIS | 87.2% |
| Revenue / Bed COMPUTED | $512K |
| Net-to-Gross HCRIS | 71.8% |
| Distress Probability ML | 45.6% |
2. Market Context & Competitive Position
IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 29.7% places it above the state median. Among 59 size-comparable peers (49-196 beds), the median margin is 3.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (49-196), prioritizing same-state peers. 59 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ENCOMPASS HEALTH DEACONESS REH (Target) | IN | 98 | $50.2M | 29.7% |
| REID HOSPITAL & HEALTH CARE SE | IN | 183 | $487.2M | 26.1% |
| IU HEALTH ARNETT HOSPITAL | IN | 194 | $426.2M | 16.1% |
| HENDRICKS REGIONAL HEALTH | IN | 130 | $423.4M | -3.6% |
| IU HEALTH NORTH HOSPITAL | IN | 153 | $413.3M | 24.2% |
| FRANCISCAN HEALTH LAFAYETTE | IN | 177 | $377.7M | 2.7% |
| ST. MARY MEDICAL CENTER INC. | IN | 180 | $319.2M | 9.5% |
| COMMUNITY HOSPITAL SOUTH | IN | 169 | $315.7M | 14.4% |
| FRANCISCAN HEALTH CROWN POINT | IN | 192 | $300.5M | 8.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $994K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $611K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $32K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $14.9M |
| + RCM Uplift | +$3.7M |
| Pro Forma EBITDA | $18.6M |
| Current Margin | 29.7% |
| Pro Forma Margin | 37.1% |
| WC Released (1x) | $1.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $22.9M | $135.3M | 5.90x | 42.6% |
| Base (11x exit) | 10.0x | 11.0x | $22.9M | $156.3M | 6.81x | 46.8% |
| Bull Case | 9.0x | 11.0x | $20.7M | $176.0M | 8.52x | 53.5% |
| Bull (12x exit) | 9.0x | 12.0x | $20.7M | $198.0M | 9.59x | 57.2% |
| Bear Case | 11.0x | 10.0x | $25.2M | $109.4M | 4.33x | 34.1% |
| Bear (11x exit) | 11.0x | 11.0x | $25.2M | $128.5M | 5.09x | 38.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 55.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 59 hospitals with 49-196 beds
- Same-state prioritization (n=60)
- Comp margins: P25=-11.5% / P50=3.5% / P75=14.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.